Newbury Pharmaceuticals AB (OSTO:NEWBRY) EBITDA Margin % : -7.83% (As of Feb. 2025)

Newbury Pharmaceuticals AB EBITDA Margin % Chart

Newbury Pharmaceuticals AB Quarterly Data
	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
EBITDA Margin %	Get a 7-Day Free Trial													-132.28	-567.17	11.37	-57.49	-7.83

Competitive Comparison of Newbury Pharmaceuticals AB's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Newbury Pharmaceuticals AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Newbury Pharmaceuticals AB's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Newbury Pharmaceuticals AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Newbury Pharmaceuticals AB's EBITDA Margin % falls into.

Newbury Pharmaceuticals AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Newbury Pharmaceuticals AB's EBITDA Margin % for the fiscal year that ended in Aug. 2024 is calculated as

Newbury Pharmaceuticals AB's EBITDA Margin % for the quarter that ended in Feb. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newbury Pharmaceuticals AB  (OSTO:NEWBRY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Newbury Pharmaceuticals AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB Business Description